Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Male pattern baldness does not cause an increased risk of prostate cancer.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Six new hair loss factors in men not linked to female hair loss.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Google Trends data on facial cosmetic procedures matches actual surgery numbers, showing it can help plastic surgeons understand public interest.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

PRGF treatment safely and effectively helps hair loss.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Systematic reviews on platelet-rich plasma therapy for hair loss have many quality issues.

A mother's diet at conception can cause lasting genetic changes in her child.

Accurate diagnosis and effective oral treatment are key to managing tinea capitis and preventing its spread.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Four genetic risk spots found for hair loss, with WNT signaling involved and a link to curly hair.

Hair follicle stem cells are a promising source for tissue repair and treating skin or hair diseases.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Bald men may have a lower risk of testicular cancer.

Breast cancer may be detectable through changes in scalp hair lipids.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Elastic Net DNA methylation clocks are inaccurate for predicting age and health status; a "noise barometer" may better indicate aging and disease.

Tiny RNA molecules help control the growth of plant hairs.